CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

CTO DES Hypertension Imaging Modalities PCI Pharmacology PE Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
CTO DES Hypertension Imaging Modalities PCI Pharmacology PE Radial Regulatory Structural Disease Valvular Interventions

Back to Top

Advertisement

Advertisement

US Company Directory


Johnson & Johnson MedTech (Heart Recovery)

1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08901

PHONE: 1-800-422-8666

down-arrow Created with Sketch.
down-arrow Created with Sketch.

Other Devices / Catheter-Based Cardiac Assist Devices

View Chart
Company Name Product Name Max Flow Rate (L/m) Catheter Size (F) Pump Size (F) Surface Across Valve Insertion Method Duration of Support US FDA Indicated Use
Johnson & Johnson MedTech (Heart Recovery) Impella 2.5 2.5 9 12 Smooth Percutaneous via femoral artery ≤ 4 days or as needed for patient AMI shock and high-risk PCI
Johnson & Johnson MedTech (Heart Recovery) Impella 5.0 5 9 21 Smooth Peripheral via arterial cutdown ≤ 6 days or as needed for patient AMI shock
Johnson & Johnson MedTech (Heart Recovery) Impella 5.5 with SmartAssist > 6 9 21 Cannula Axillary and direct aortic insertion ≤ 14 days or as needed for patient AMI shock
Johnson & Johnson MedTech (Heart Recovery) Impella CP with SmartAssist 4.3 9 14 Smooth Percutaneous via femoral artery ≤ 4 days or as needed for patient AMI shock and high-risk PCI
Johnson & Johnson MedTech (Heart Recovery) Impella LD 5 9 21 Smooth Direct, surgical insertion ≤ 6 days or as needed for patient AMI shock
Johnson & Johnson MedTech (Heart Recovery) Impella RP 4 11 22 Smooth Percutaneous via femoral vein ≤ 14 days or as needed for patient Acute right heart failure, AMI shock

More Categories:

Balloons Catheters Sheaths Stents Structural Heart Valves Wires Other Devices View All

Advertisement

Latest News


November 3, 2026

SPIRARE II Post Hoc Analyses Presented for Jupiter Endovascular’s Vertex Thrombectomy System

November 3, 2026

Primary Endpoint Results Presented From Medtronic’s SPYRAL AFFIRM Postapproval RDN Study

November 3, 2026

Philips Announces United States Launch of HyperVue Integrated System

Most Read Articles


enVast™: Engineered for Coronary Thrombectomy

By Marco Valgimigli, MD, PhD

AeroShield™ Elite: Passive Protection Without Compromise

By William Gray, MD

When and How to Escalate MCS in Cardiogenic Shock

By Jessica Maria Gonzalez, MD, and Aditya Bharadwaj, MD

Back to Top
CTO DES Hypertension Imaging Modalities PCI Pharmacology PE Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions Pulmonary Embolism

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button